Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 21, 2021

BUY
$8.38 - $10.18 $444 - $539
53 Added 15.27%
400 $3,000
Q2 2021

Jul 26, 2021

SELL
$9.9 - $11.56 $9 - $11
-1 Reduced 0.29%
347 $3,000
Q4 2020

Jan 20, 2021

BUY
$8.61 - $11.04 $8 - $11
1 Added 0.29%
348 $3,000
Q3 2020

Oct 19, 2020

BUY
$8.57 - $12.69 $857 - $1,269
100 Added 40.49%
347 $3,000
Q2 2019

Jul 24, 2019

BUY
$8.12 - $15.72 $2,005 - $3,882
247 New
247 $2,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $23.2B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Ellis Investment Partners, LLC Portfolio

Follow Ellis Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellis Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ellis Investment Partners, LLC with notifications on news.